E
Kezar Life Sciences, Inc. KZR
$3.96 $0.000.00% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Net Income 36.40% 23.56% 37.33% 12.08% 11.36%
Total Depreciation and Amortization -6.90% -3.46% -7.50% -6.47% 4.82%
Total Amortization of Deferred Charges -35.38% 148.44% 11.86% 10.34% 10.17%
Total Other Non-Cash Items -43.48% 8.85% -47.78% -59.78% 47.43%
Change in Net Operating Assets -228.04% 9.10% -92.00% 123.21% 374.87%
Cash from Operations 24.87% 24.81% 11.35% 13.42% 21.15%
Capital Expenditure -- -- -1,000.00% 86.76% --
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -6.70% -32.62% -14.79% 28.72% -16.21%
Cash from Investing -6.70% -32.66% -14.83% 29.54% -7.48%
Total Debt Issued -- -- -- -- --
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock -37.50% -- -20.34% -100.00% -85.34%
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash from Financing -2,366.07% -- -20.34% -100.00% -85.34%
Foreign Exchange rate Adjustments 966.67% 171.43% -297.37% 169.57% 160.00%
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 44.60% -92.89% -23.39% 508.57% 40.70%